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Abstract
Background: Optimizing user satisfaction with alcohol-based hand rubs (ABHR) may be vital to enhance hand
hygiene performance. This study tested the tolerability and acceptability of a new ABHR (EVO9; Ecolab) in healthcare
workers under daily working conditions and evaluated the practicability of the corresponding WHO protocol.
Methods: We strictly applied the WHO single product ABHR evaluation protocol. A trained observer assessed hand
skin conditions of healthy volunteers using at least 30 ml ABHR per day during their clinical work at baseline, day
3–5 and one month (visit 1–3). Participants rated ABHR tolerability and acceptability at visit 2 and 3. Additionally,
we registered study time for participants and study team.
Results: Among 46 volunteers, 76% were female; 37% nurses, 28% physicians. Skin was observer-rated “not” or
“incidentally” dry in 64.4%, 77.8%, and 90.9% participants at visit 1, 2, and 3, respectively. EVO9 was scored ≥5
(progressive scale, 1–7) for appearance, intactness, moisture content, and sensation by 95.7%, 97.7%, 88.9%, and
97.8% participants at visit 3, respectively. All WHO benchmarks were exceeded except for “speed of drying” at visit
2, and “texture” at visit 2 and 3. Cumulative study time expenditure was 14 days for the observer and four days
for participants.
Conclusions: EVO9 was well tolerated and accepted according to the WHO single ABHR evaluation protocol with
the potential for improvement for stickiness. The WHO protocol is feasible but requires considerable time and
logistics. It does not preclude bias, in this case especially due to the necessary switch to personal dispensers.
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Background
The World Health Organisation (WHO) ‘Guidelines
on Hand Hygiene in Healthcare’ were issued by WHO
Patient Safety in May 2009 on the occasion of the launch
of the “Save Lives: Clean Your Hands” initiative [1]. Since
publication of the guidelines there has been convincing
evidence of an improvement in hand hygiene (HH)
practices and that, in turn, has resulted in a reduction
of hospital acquired infections and/or transmission of
multidrug-resistant organisms [2-6]. The WHO suggests
five avenues of action as a multimodal strategy of which
system change, i.e. facilitated access to well-tolerated
alcohol-based handrub (ABHR), is one component.
However, not all initiatives to improve HH are suc-
cessful and, sustaining high levels of HH compliance
among health care personnel are ambitious goals [7,8].
Some of the self-reported reasons given for failing to
correctly apply hand cleansing include lack of time,
inconveniently located and/or scarcity of facilities, forget-
fulness, and agents that cause skin irritations and dryness
[9]. In fact, skin tolerability has been reported as one of
the main reasons for disinclination towards HH [10-12].
User's acceptance and good skin tolerability are there-
fore considered being among the most important cri-
teria for the selection of an ABHR [1]. Thus, a product
that is pleasant to use with no harmful effect to the
hands is a major asset for the promotion of optimal
hand hygiene practices.* Correspondence: aline.wolfensberger@usz.ch
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The WHO provides and promotes the application of
two study protocols to evaluate the acceptability and
tolerability of an ABHR: “Method 1” for testing a single
product planned to be introduced, “Method 2” for com-
paring two different products [13-15].
The aim of this study was to investigate the tolerability
and acceptability of a new ABHR (EVO9; Ecolab) in
healthcare workers by using an established WHO proto-
col, to report the experience with this protocol under
real life conditions, and to exemplarily quantify the ef-
fort necessary to conduct such a formal evaluation. The
study ABHR has successfully been tested according to
the European Norm EN1500 and EN12791 and has been
registered with Swissmedic under the registration num-
ber CHZN3080.
Methods
Study setting and protocol
The study was conducted between May and July 2013 at
the Division of Infectious Diseases and Infection Control,
University Hospital Zurich, Zurich, Switzerland. The me-
thodology was based on the published WHO protocol
“Method 1 for Evaluation of tolerability and acceptability
of alcohol-based hand rub in use or planned to be intro-
duced” [13]. Three minor modifications were made to the
WHO protocol: skin type was assessed with by observer
according to Fitzpatrick skin sensitivity type (and not self-
assessed by participant), participants were allowed to
continue their usual hand care products during the
whole study period, and a question on product accessi-
bility was added.
Study population
The study was carried out in healthy adults of ≥18 years
of age. Participants were not allowed to have significant
skin or systemic disease or any intolerance to any com-
ponent of the test preparation. The observer was a me-
dical doctor (AW) trained by an expert who participated
in establishing and validating the WHO protocol (MNC,
see acknowledgements).
Study design and endpoints
Each participant received the test product in a 100 ml per-
sonal dispenser. Three visits took place: a baseline visit 1
at day 0, visit 2 between day 3 and 5 of product use, visit 3
at the study end after one month of product use.
The quantity of product used was measured at visit 2
and 3 to assure a minimal mean daily use of at least
30 ml of the test product.
The primary endpoint was the observer assessment of
skin condition of the participants’ hands using validated
scales with higher scores meaning worse conditions in-
cluding the items redness (score, 0–4), scaliness (0–3),
fissures (0–3), and visual scoring of skin (1–5). This pri-
mary endpoint was evaluated at all three study visits [16].
Secondary endpoints were participant assessment of skin
tolerability on a rating scale 1–7 including the items
appearance, intactness, moisture content, and sensation
(all, ‘abnormal’-‘normal’) and overall skin integrity (‘very
altered’-‘perfect’) and product acceptability including the
items color (‘unpleasant’-‘pleasant’), smell (‘unpleasant’-
Table 1 Participants characteristics
Question Answer Value (N = 46)
Do you have non work-
related activities causing
skin damage?*
Yes 12 (26.0%)
Do you normally use of a
skin care hand lotion/
cream?*
As often as possible 2 (4.2%)
Several times per day 14 (30.4%)
Once per day 7 (15.2%)
Sometimes depending on
season
15 (32.6%)
Rarely 5 (10.9%)
Never 2 (4.2%)
Do you develop irritative
dermatitis?**
Never 31 (67.4%)
Sometimes depending on
season
13 (28.3%)
Always 0
Do you develop atopic
dermatitis?**
Yes 2 (4.2%)
Do you develop allergic
rhinitis/allergic
conjunctivitis?**
Yes 15 (32.6%)
Are you asthmatic?* Yes 2 (4.2%)
Do you have Intolerance
to alcohol?*
Yes 0
Do you work part time?* Yes 19 (41.3%)
Full time equivalent
≤ 50%
4 (8.7%)
For how long have you
been using alcohol-based
products at work?*
First time 4 (8.7%)
<1 year 2 (4.2%)
>1 and < 5 years 6 (13.0%)
>5 years 33 (71.7%)
Do you think you can
improve your own hand
hygiene compliance?*
Yes 26 (56.5%)
Perhaps 10 (21.7%)
It may be difficult to use
an alcohol based hand
rub because of…
Forgetfulness Mean, 5.1;
median, 6
Lack of time Mean, 5.5;
median, 6
(Likert scale 1–7; 1,
always; 7, never)*
Damaged skin Mean, 5.4;
median, 6
Poor product
accessibility***
Mean, 5.9;
median, 6
*One missing answer.
**Two missing answers.
***Question added by the authors outside of the WHO protocol.
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‘pleasant’), texture (‘very sticky’-‘not sticky at all’), irritation
(‘very irritating’-‘not irritating’), drying effect (‘very much’-
‘not at all’), ease of use (‘very difficult’-‘very easy’), speed of
drying (‘very slow’-‘very fast’), application (‘unpleasant’-
‘pleasant’), overall evaluation (‘dissatisfied’-‘very satisfied’).
Participant evaluations were carried out at visit 2 and
visit 3.
WHO hand rub quality benchmarks
WHO defined benchmark criteria for an acceptable
quality for ABHR to help purchasing decision-making.
Objective scores for skin condition must score lower
than 2 in ≥ 75% of assessments. Participant evaluation of
skin condition must score above 4 in ≥ 75% of cases. Par-
ticipant acceptance must score for color and smell above
4 in ≥ 50% of the answers and above 4 in ≥ 75% of ratings
for the other items in this dimension [13].
Statistical analysis
The results were interpreted descriptively according to
the WHO ‘Method 1’ [13].
Evaluation of WHO protocol feasibility and applicability
To evaluate the practicability of the WHO protocol, ob-
server and participant time was registered.
The study was formally accepted by the Ethics board
of the Canton of Zurich (ID number KEK-ZH-Nr. 2012–
0444).
Results
Participants
Overall, 46 participants out of a staff of approximately
90 were included after having given their informed con-
sent. Participant mean age was 35 years (standard devia-
tion, ±12); 35 (76%) were female; 17 (37%) were nurses,
13 (28%) medical doctors, five (11%) students, and 11
(24%) belonged to other professions. Fitzpatrick skin sun
sensitivity types [17] were: type II, 28 (62%); type III, 14
(31%); and type I, IV, V, one participant (2%) each. Eight
participants (17%) were smokers. The remaining partici-
pant characteristics are shown in Table 1, data on hand
hygiene behavior and product preference in Table 2.
Skin tolerability by observer evaluation
Skin condition met the WHO benchmark at all visits
and scores improved over time (Table 3).
Table 2 Hand hygiene behavior and preference
of product
Visit 2
(day 3–5)
Visit 3
(day 28)
N = 46 N = 46
During how many
consecutive days have you
used the test product? (days)
3 26 (56.5%) 7 (15.2%)
4 7 (15.2%) 7 (15.2%)
5 8 (17.4%) 17 (37.0%)
6 2 (4.3%) 4 (8.7%)
7 0 0
>7 0 10 (21.7%)
Missing 3 (6.5%) 1 (2.2%)
How often do you have
direct contact with patients
during your working day?
(contacts)
<1 13 (28.3%) 12 (26.1%)
1 - 5 2 (4.3%) 5 (10.7%)
6 - 10 6 (13.0%) 6 (13.0%)
11 - 15 8 (17.4%) 7 (15.2%)
>15 15 (32.6%) 14 (30.4%)
Missing 2 (4.3%) 2 (4.3%)
In what percentage of times
where hand hygiene is
recommended, do you really
clean your hands?
≤60% 3 (6.6%) 2 (4.4%)
70% 7 (15.2%) 3 (6.5%)
80% 6 (13.0%) 10 (21.7%)
90% 13 (28.3%) 10 (21.7%)
100% 16 (34.8%) 18 (39.1%)
Missing 1 (2.2%) 2 (4.3%)
Has the present study
changed your hand hygiene
practice?
Yes 17 (37.0%) 17 (37.0%)
Missing 1 (2.2%) 1 (2.2%)
During your last 5
opportunities for hand
hygiene, how many times
did you use handrubbing to
clean your hands? (times)
≤2 0 1 (2.2%)
3 6 (13.0%) 4 (8.7%)
4 12 (26.1%) 11 (24.0%)
5 26 (56.5%) 29 (63.0%)
Missing 2 (4.3%) 2 (4.3%)
On average, how often do
you practice hand hygiene
during a working hour
(during the test period)?
(times)
<1 2 (4.3%) 2 (4.3%)
1 – 5 20 (43.5%) 19 (41.3%)
6 – 10 12 (26.1%) 6 (13.0%)
11 – 15 6 (13.0%) 9 (20.0%)
>15 5 (10.7%) 9 (20.0%)
Missing 1 (2.2%) 1 (2.2%)
Are there differences
between the test product
and the product used in your
hospital? (Likert scale 1 to 7;
1, major difference; 7, no
differences)
Mean 3.6 3.3
Median 3 3
Which product do you
prefer?
Usual product 7 (15.2%) 7 (15.2%)
Test product 26 (56.5%) 30 (65.2%)
No preference 11 (23.9%) 8 (17.4%)
Missing 2 (4.3%) 1 (2.2%)
Table 2 Hand hygiene behavior and preference
of product (Continued)
Do you think that the test
product could improve your
hand hygiene compliance?
(Likert scale 1 to 7; 1, yes
absolutely; 7, not at all)
Mean 3.6 3.4
Median 4 3
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Skin tolerability by participant evaluation
The second WHO criterion for skin tolerability by par-
ticipant rating was also fulfilled at both visit 2 and 3
(Figure 1).
Product acceptability by participate evaluation
The WHO criteria for product acceptability for the
items color and fragrance was fulfilled at each time
point. The WHO criteria for all the other items were
met in all but two categories at visit 2 and in all but one
category at visit 3. The investigational product failed to
meet the WHO criterion for acceptability by study par-
ticipants only for texture at visits 2 and 3 and speed of
drying at visit 2. Additionally, while still meeting WHO
benchmark ‘smell after application’ received lower scores
than the other items (Figure 2).
Adverse events
One non-serious adverse event (AE) was reported during
the study period. The affected participant complained
about erythema and pruritus on his/her hands, which
was determined to be a local allergic or irritative reac-
tion to the investigational product. The AE was rated as
mild, lasted for four hours and disappeared without any
treatment. The participant reported similar skin reac-
tions to other products in the past and was withdrawn
from the study without further investigation. There were
no serious AEs.
Product consumption
The test ABHR was used at a mean quantity of 35 ml
per day at visit 2 and 37 ml per day thereafter. The re-
quired frequency of use criterion according to the WHO
Table 3 Evaluation of skin condition by trained observer
Item Skin condition (score) Visit 1
(day 0)
Visit 2
(day 3–5)
Visit 3
(day 28)
Redness N 46 46 45
No redness (0) 11 (24%) 16 (35%) 19 (42%)
Slight redness or blotchy (1) 28 (61%) 25 (54%) 22 (49%)
Moderate redness (2) 7 (15%) 4 (9%) 4 (9%)
Strong redness (3) 0 0 0
Fiery red with oedema (4) 0 1 (2) 0
Proportion with score < 2* 84.7% 89.1% 91.1%
Scaliness N 46 46 45
No scales (0) 29 (63%) 28 (61%) 33 (73%)
Very slight sporadic scales (1) 13 (28%) 16 (35%) 11 (24%)
Moderate scales (2) 4 (9%) 2 (4%) 1 (2%)
Considerable scales (3) 0 0 0
Proportion with score < 2* 91.3% 95.6% 97.7%
Fissures N 46 46 44
No fissures (0) 30 (65%) 34 (74%) 37 (84%)
Very fine fissures (1) 14 (30%) 12 (26%) 5 (11%)
Broad, sporadic or several fissures (2) 2 (4%) 0 2 (5%)
Widespread cracks with haemorrhage or exudate (3) 0 0 0
Proportion with score < 2* 95.7% 100% 95.7%
Global score N 45 46 44
No dry skin or irritations (0) 4 (9%) 8 (17%) 17 (39%)
Incidental dry skin (1) 25 (56%) 28 (61%) 23 (52%)
Dry skin and/or redness (2) 13 (29%) 10 (22%) 3 (7%)
Very dry, whitish rough skin (3) 2 (4%) 0 1 (2%)
Chappy skin without haemorrhage or exudate (4) 1 (2%) 0 0
Widespread fissures with haemorrhage or exudate (5) 0 0 0
Proportion with score < 2* 64.4% 77.8% 90.9%
*WHO benchmark ≥ 75%.
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protocol of a minimum consumption of 30 ml per day
was met.
Practicability assessment
Information, instruction and informed consent proce-
dures required 15 minutes per participant. Time for fil-
ling in the questionnaires required five minutes each,
time for meeting the observer for evaluation of skin
state, distribution and return of bottles accounted for
three minutes each. In total every test person spent
40 minutes on study procedures, resulting in 30 hours
for all the 46 participants. The observer had to pre-
arrange the study, including preparation of the bottles
and questionnaires, which took two working days. Time
expenditure for information and recruitment of partici-
pants was about two working days. The objective skin
evaluation, distribution and return of questionnaires and
bottles and measurement of product consumption took
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Figure 1 Skin tolerability by participant evaluation. Proportion of participants rating skin tolerability items (Likert scale 1 to 7) > 4; dashed line,
WHO minimal pass criteria for alcohol-based hand rub. Visit 1 took place at baseline, visit 2 at day 3–5 and visit 3 at one month of test alcohol-based
hand rub use.
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about 60 minutes per participant, summing up to six
working days in this case. Data analysis and calculation
took another four working days. In total the observer/
investigator spent 14 working days for conducting the
evaluation.
Discussion
The aim of this study was to investigate the skin toler-
ability and product acceptability of a new ABHR (EVO9;
Ecolab) in healthcare workers under daily working con-
ditions and to evaluate the practicability of the WHO
protocol “Method 1 for evaluation of tolerability and ac-
ceptability of alcohol-based hand rub in use or planned
to be introduced” (WHO 2009). To our knowledge this
is the first formal report on the application of the above-
mentioned WHO protocol.
The primary endpoint concerned participant skin con-
dition rated by a trained observer according to well-
established dermatological criteria. The test product
surpassed the corresponding WHO benchmark. More-
over, there was a trend to improved ratings with time of
use in follow-up visits. These findings were corroborated
by participants reporting above-benchmark ratings for
“skin tolerability by participant” in every category, i.e.,
appearance, intactness, moisture content, and sensation,
at both study visits. In terms of acceptability the test
product failed the WHO benchmark only for texture at
visit 2 and 3 and speed of drying at visit 2. After one
month of use, 67% of participants preferred the investi-
gational product over the product they normally used.
However, the results have to be interpreted with some
caution. Study procedures made it necessary to provide
participants with personal bottles of ABHR, which pre-
sented a novelty against the habitual bed- and wall-
mounted dispensers in our hospital. Many participants
told the study observer that they liked the personal
ABHR bottles. Such preference might have led to a posi-
tive halo effect on product judgment. If feasible, change
of provision form for the test product should be avoided
since it can lead to positive or negative confounding. For
the sake of a real world assessment we allowed partici-
pants to continue their habitual hand cream use during
the study. This might have offset overall skin condition
results favorably but did most likely not change trends
over time. Additionally, the quantification in Table 1 that
is in accordance with the WHO protocol, allows for
comparison with results of other studies. Lastly, it is well
known that in an non-blinded study the results tend to
be biased towards a beneficial effect of the product
under study [18]. This flaw would be mitigated when
using the WHO “Method 2” to compare two different
products using a randomized blinded protocol.
The WHO protocol proofed to be clear and easy to
understand. Yet, its implementation presented some
challenges. First, the necessary 14 working days for the
observer and four cumulative working days for partici-
pants might be perceived as an unusually high workload
given the considerable number of potential ABHR avail-
able for testing. Thus, if used to select an ABHR for an
institution it is advisable to apply this protocol to a li-
mited number of serious ABHR candidates. Second, par-
ticipants had to use the product for four weeks without
interruption for more than five days, otherwise the study
duration had to be extended for the same number of
days. Fulfilling these requirements in part-time HCWs
on irregular shifts proved to be challenging. Third, to pre-
vent inter-individual variation, all skin assessments had to
be carried out by the same investigator requiring the per-
son to be available for the whole assessment period.
Conclusion
The new ABHR (EVO9; Ecolab) was well tolerated and
user-accepted with a potential for improvement regar-
ding texture, i.e. stickiness. While the subjective usability
and tolerability rating by the users should be interpreted
with caution, the skin tolerability assessed by a trained
observer may be more reliable. The WHO protocol proofed
to be useful but demanding for everyday application.
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